Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Authors:
- M. Leann DoddMDM. Leann Dodd
- Kevin J. KlosKKKevin J. Klos
- James H. BowerJBJames H. Bower
- Yonas E. GedaYGYonas E. Geda
- Keith A. JosephsKJKeith A. Josephs
- J. Eric AhlskogJAJ. Eric Ahlskog
Top Cited Papers
Open Access
- 1 September 2005
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 62 (9) , 1377-1381
Abstract
Gambling is common in our society, with multiple outlets, such as casinos, Internet Web sites, local sports betting, and so on. Gambling behavior, however, may become pathological, defined as failure to resist gambling impulses despite severe personal, family, or vocational consequences. Pathological gambling is classified as an impulse control disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria.1Keywords
This publication has 9 references indexed in Scilit:
- Pathological gambling in two patients on dopamine replacement therapy for Parkinson?s diseaseNeurological Sciences, 2004
- Dopamine Transmission in the Human Striatum during Monetary Reward TasksJournal of Neuroscience, 2004
- Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatumJournal of Neural Transmission, 2003
- Genetics of Pathological GamblingJournal of Gambling Studies, 2003
- Getting Formal with Dopamine and RewardNeuron, 2002
- Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus AccumbensThe Journal of Neuroscience, 2001
- Pre‐clinical studies of pramipexole: clinical relevanceEuropean Journal of Neurology, 2000
- Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptorsEuropean Journal of Pharmacology, 1999
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990